Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Combination Patients advanced Renal Cell Carcinoma
.
Show all posts
Showing posts with label
Combination Patients advanced Renal Cell Carcinoma
.
Show all posts
Thursday, June 27, 2019
FDA Approves Bavencio (avelumab) Plus Inlyta (axitinib) Combination for Patients with Advanced Renal Cell Carcinoma
›
In continuation of my update on axitinib Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business a...
›
Home
View web version
